Revance’s cover photo
Revance

Revance

Biotechnology Research

Nashville, Tennessee 37,486 followers

Driving innovation beyond convention

About us

We believe that science-powered innovation creates possibilities. As a privately held, fully-integrated global company, Revance is passionately driven by that philosophy in everything we do. Dedicated to offering a diverse portfolio in aesthetics, skincare, and therapeutics, our science-backed products care for individuals across the generations. By driving innovation beyond convention, we continue to research and develop differentiated products for health, beauty, and wellness.

Website
http://www.revance.com
Industry
Biotechnology Research
Company size
1,001-5,000 employees
Headquarters
Nashville, Tennessee
Type
Privately Held
Specialties
Botulinum Toxin, biotechnology, biotech, healthcare, science, and research

Locations

Employees at Revance

Updates

  • Revance reposted this

    Honored to share a bit of my founder story. It’s been the privilege of my life to build this company alongside incredible people. Excited for this conversation to inspire others to chase their entrepreneurial dreams.

    New Episode LIVE! Conversation with Jeffery Bedard Founder & Executive Chairman of Revance. This was such a fun episode for me. We talked innovation, leadership, and what it really takes to build a category-defining aesthetics brands. If you’re a founder, injector, or aesthetic industry leader, this episode is a must-watch. Jeff shares rare insight into scaling, decision-making, and shaping the future of our industry. ▶️ Watch the full episode now. Link below :) https://lnkd.in/en2eShjv This one will shift how you think about brand, business, and leadership in aesthetics.

  • Are you one of the ASDS Members headed to Chicago for the ASDS Annual Meeting? We'll see you there! Visit Revance Aesthetics at Booth 213 to discover our growing aesthetics portfolio. Join us for our Medical Affairs Filler Lab and learn all about: - DAXXIFY® - The Teoxane RHA® Collection - SkinPen® Plus, don't miss our cocktail reception and Industry Expert Talk on Thurs, Nov. 13, featuring Dr. Dee Anna Glaser for a presentation titled "Elevating Your Practice with the Revance Aesthetics Portfolio.” See you soon! Please note that you must be registered for ASDS. Contact your Professional Aesthetic Consultant for details. #ASDS #ASDSMeeting #ASDSMembers #RevanceAesthetics For information including Boxed Warning and Medication Guide, see https://lnkd.in/e_R678rW DAXXIFY® (daxibotulinumtoxinA-Ianm) is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face. Call your doctor for medical advice about side effects. Intended for US audiences.Please see Important Safety Information for DAXXIFY®, including BOXED WARNING, at the end of the post. SkinPen® is owned by Crown Aesthetics, a Revance company.

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +2
  • View organization page for Revance

    37,486 followers

    Elevate the Aesthetic Journey? Check ✅ This past weekend we hosted aesthetic providers at our Revance Headquarters in Nashville, TN for an educational experience! Thank you to all who attended, and a special thank you to our renowned speakers Olivia Salmen, Suneel Chilukuri MD and Sachin Shridharani for sharing your expertise. For those who joined us, let us know what your favorite part of the weekend was in the comments! Interested in how you can attend in the future? Be sure to ask your Professional Aesthetic Consultant to learn how to participate!

  • View organization page for Revance

    37,486 followers

    Innovation extends far beyond the initial product launch. It encompasses continuous improvement, adaptation and even business model transformation. The real challenge and opportunity - ensuring the current treatment options reach the right patients. At Revance Therapeutics, that’s exactly our focus as we broaden our efforts to drive adoption of DAXXIFY® across the physician and patient communities. Our goal: reshape the treatment paradigm for patients living with cervical dystonia. Watch for Important Safety Information. For Full Prescribing Information, including Boxed Warning and Medication Guide, see https://lnkd.in/ezYpMmtH DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine that is injected into muscles and used to treat cervical dystonia in adults. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, and breathing due to weakening of associated muscles can be a sign of a life-threatening condition. The most common side effects are headache, injection site pain, injection site redness, muscle weakness, and upper respiratory tract infection. Call your doctor for medical advice about side effects. Intended for US audiences.

    • No alternative text description for this image
  • View organization page for Revance

    37,486 followers

    Thanks for joining us in NYC for connections and conversations as inspiring as the city itself! Revance was thrilled to welcome media, influencers, and local customers to learn more about our growing portfolio and the future of aesthetics, including a panel featuring our CMO, Adelle Walker, and expertise on DAXXIFY® from Dr. Doris Day, The Teoxane RHA® Collection from Dr. Jody Comstock and SkinPen® from Dr. Suneel Chilukuri. #DAXXIFY #TeoxaneRHACollection #SkinPen #RevanceAesthetics #Revance

Affiliated pages

Similar pages

Browse jobs

Funding

Revance 17 total rounds

Last Round

Post IPO equity

US$ 100.0M

See more info on crunchbase